Anti-inflammatory therapy shows promise in slowing progression of multiple sclerosis

(University of Alberta Faculty of Medicine & Dentistry) Intranasal administration of an anti-inflammatory drug helped reduce disease progression in a preclinical model of multiple sclerosis, according to recent research out of the University of Alberta.